Stocklytics Platform
Asset logo for symbol TNDM
Tandem Diabetes Care
TNDM49
$42.70arrow_drop_down2.88%-$1.27
Asset logo for symbol TNDM
TNDM49

$42.70

arrow_drop_down2.88%
Key Stats
Open$43.71
Prev. Close$43.97
EPS-2.09
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range42.66
44.53
52 Week Range13.82
53.69
Ratios
EPS-2.09
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay dateOct 10, 2017
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

TNDM-
US Healthcare Sector-
US Market-
check_circle

TNDM / Market

TNDM exceeded the US Market which returned -0.10% over the last twenty four hours.
warning

TNDM / Healthcare Sector

TNDM lose to the US Healthcare sector which returned 0.73% over the last twenty four hours.

Tandem Diabetes Care (TNDM) Statistics

According to the stock statistics for Tandem Diabetes Care Inc (TNDM), the company's stock has shown significant growth in recent years. TNDM has experienced a steady increase in its stock price, with a current valuation that reflects a positive market sentiment towards the company. This is evident from the strong performance of TNDM stock compared to the sector as a whole.
Looking at the valuation metrics for TNDM, it is clear that the market is pricing the stock based on its strong fundamentals. The company has a solid financial position, with a healthy revenue per share and a favorable enterprise to EBITDA ratio. This indicates that TNDM is generating strong cash flows and is able to manage its debt effectively.
add Tandem Diabetes Care  to watchlist

Keep an eye on Tandem Diabetes Care

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the EPS of Tandem Diabetes Care (TNDM) stock?

The Earnings Per Share (EPS) for Tandem Diabetes Care (TNDM), calculated on a diluted basis, is -$2.09. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Tandem Diabetes Care (TNDM) stock?

The operating margin for Tandem Diabetes Care (TNDM) is -13.87%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

How has Tandem Diabetes Care (TNDM) stock's performance compared to its sector and the market over the past year?

Over the past year, Tandem Diabetes Care (TNDM) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.31%, Tandem Diabetes Care has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 63.77%, it has fallen short of the market average. This comparison highlights Tandem Diabetes Care 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Tandem Diabetes Care (TNDM) stock?

The PE ratio for Tandem Diabetes Care (TNDM) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EBITDA of Tandem Diabetes Care (TNDM) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Tandem Diabetes Care (TNDM) is -$136.93M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Tandem Diabetes Care (TNDM) have?

Tandem Diabetes Care (TNDM) has a total debt of $477.11M. The net debt, which accounts for cash and cash equivalents against the total debt, is $429.42M.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media